Vargas, Mildred .
HRN: 21-17-27 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2025
CEFUROXIME 500MG (TAB)
05/21/2025
05/28/2025
ORAL
500mg
BID
S/P NSD; UTI
Waiting Final Action
05/22/2025
CEFUROXIME 500MG (TAB)
05/22/2025
05/28/2025
PO
500mg
BID
UTI
Waiting Final Action